Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedures in benign paroxysmal positional vertigo (BPPV) ...
HAMILTON, BERMUDA / ACCESSWIRE / June 15, 2023 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq:CYTO), a company dedicated to developing therapeutics that address important unmet ...
Dose dependent improvement in balance tests over placebo in Part A of TRAVERS trial Improvement 1.9 to 2.4 times greater with highest dose than with placebo Trial to proceed with Part B to test AM-125 ...
Altamira Therapeutics (NASDAQ:CYTO) stock soared ~62% on Wednesday after the company said detailed results from a phase 2 trial of AM-125 (intranasal betahistine) in surgery-induced acute vestibular ...
* AURIS MEDICAL - EXPECT TO RECEIVE TOP-LINE DATA FROM COMPLETED AM-201 TRIAL IN EARLY MAY AND INTERIM DATA FROM AM-125 TRIAL IN Q3 Source text for Eikon: Further company coverage: ...
Betahistine, a small molecule structural analog of histamine, acts as an agonist at the H1 histamine receptor and as an antagonist at the H3 histamine receptor. Unlike histamine, it crosses the ...
The vertigo treatment pipeline is steadily advancing, with numerous companies exploring novel therapies targeting its complex causes. Common in older adults, vertigo is often managed with vestibular ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. BETAHISTINE VIATRIS contains the active ingredient betahistine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results